Bronchopulmonary Dysplasia in Post-Surfactant Era: Results of an Objective Assessment of the Disease
https://doi.org/10.15690/vsp.v14.i4.1392
Abstract
Modern methods of respiratory support have led to the transformation of the course of bronchopulmonary dysplasia. A significant role is played by the use of surfactant preparations for the prevention of respiratory distress syndrome and subsequent formation of bronchopulmonary dysplasia in premature infants. In this connection, an objective assessment of the efficacy of surfactant replacement therapy is required. The article presents the results of studying the patterns of development of bronchopulmonary dysplasia in premature infants (n =121) of different gestational age. It was shown that a new form of moderate or mild bronchopulmonary dysplasia prevailed in extremely premature infants in the course of surfactant replacement therapy. Children of a gestational age greater than 32 weeks who do not require surfactant therapy usually have typical bronchopulmonary dysplasia.
About the Authors
I. V. Davydova
Scientific Center of Children’s Health, Moscow, Russian Federation
Sechenov First Moscow State Medical University, Moscow, Russian Federation
Russian Federation
Russian Federation
A. V. Anikin
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation
Russian Federation
O. V. Kustova
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation
Russian Federation
A. V. Sidenko
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation
Russian Federation
E. Yu. Basargina
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation
Russian Federation
E. V. Pavlyukova
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation
Russian Federation
V. K. Pozharishchenskaya
Scientific Center of Children’s Health, Moscow, Russian Federation
Russian Federation
Russian Federation
References
1. Баранов А. А., Намазова-Баранова Л. С., Давыдова И. В. Современные подходы к профилактике, диагностике и лечению бронхолегочной дисплазии. М.: ПедиатрЪ. 2013. С. 17–34.
2. Greenough A., Kotecha S., Vrijlandt E. Bronchopulmonary dyspla sia: current models and concepts. Eur. Respir. Mon. 2006; 37: 217–233.
3. Рындин А. Ю., Антонов А. Г. Патент на изобретение № 2416388 от 20.04.2011 г. «Способ профилактики бронхолегочной дисплазии у новорожденных с очень низкой и экстремально низкой массой тела при рождении». М. 2011.
4. Jobe A. H., Bancalari E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2001; 163: 1723–1729.
5. Figueras-Aloy J., Serrano M. M., Rodriguez J. P., Perez C. F., Serradilla V. R., Jimenez J. Q., Gonzalez R. J. SEN1500 Spanish Neonatal Network. Antenatal glucocorticoid treatment decreases mortality and chronic lung disease in survivors among 23-to 28-week gestational age preterm infants. Am. J. Perinatol. 2005; 22 (8): 441–448.
6. Антонов А. Г., Борисевич О. А., Буркова А. С., Ионов О. В., Крючко Д. С., Ленюшкина А. А., Рындин А. Ю., Филиппов О. С., Чумакова О. В., Терехова Ю. Е. Методическое письмо «Интенсив ная терапия и принципы выхаживания детей с экстремально низкой и очень низкой массой тела при рождении». Под ред. Е. Н. Байбариной, Д. Н. Дегтярёва. М. 2011. 72 с.
7. Engle W. A. Committee on Fetus and Newborn: Surfactant Replaycement Therapy for Respiratory Distress in the Preterm and Term Neonate. Pediatrics. 2008; 121: 419–432.
8. Kribs A., Hartel C., Kattner E., Vochem M., Kuster H., Moller J. et al. Surfactant without Intubation in Preterm Infants with Respiratory Distress: First Multi-center Data. Сlin. Paеdiatr. 2010; 222: 13–17.
9. Copel W., Kribs A., Hartel C., Avenarius S., Teig N., Groneck P. et al. Less invasive surfactant administration in associated with improved pulmonary outcomes in spontaneously breathing preterm infants. Acta Paеdiatr. 2015; 104 (3): 241–246.
10. Mahut B., De Blic J., Emond S. Chest computed tomography findings in bronchopulmonary dysplasia and correlation with lung function. Arch. Dis. Child. Fetal Neonat. Ed. 2007; 92 (6): 459–464.
11. Shin S. M., Kim W. S., Cheon J. E., Kim H. S., Lee W., Jung A. Y., Kim I. O., Choi J. H. Bronchopulmonary dysplasia: New High Resolution Computed Tomography Scoring Sistem and Correlation between the High Resolution Computed Tomography Score and Clinical Severity. Korean J. Radiol. 2013; 14 (2): 350–360.
12. Sarria E. E., Mattiello R., Rao L., Tiller C. J., Poindexter B., Applegate K. E. еt al. Quantitative assessment of chronic iung disease of infancy using computed tomography. Eur. Respir. Crit. J. 2012; 39: 992–999.
13. Aukland S. M., Rosendahl K., Owens C. M., Fosse K. R., Eide G. E., Halvorsen T. et al. Neonatal bronchopulmonary dysplasia predicts abnormal pulmonary HRCT scans in long-term survivos of extreme preterm birth. Thorax. 2009; 64: 405–410.
14. Ochiai M., Hikino S., Yabuuchi H., Nakayama H., Sato K., Ohga S., Hara T. A new scoring system for computed tomography of the chest for assesing the clinical status of bronchopulmonary dysplasia. J. Pediatr. 2008; 152: 90–95.
15. Классификация клинических форм бронхолегочных заболеваний у детей. Под ред. А. Г. Чучалина. М. 2009. С. 9–10.
16. Яцык Г. В., Давыдова И. В., Кустова О. В., Симонова О. И., Цыгина Е. Н., Смирнов И. Е. Патент на изобретение № 2401066 от 10.10.2010 г. «Способ оценки степени тяжести бронхолегочной дисплазии». М. 2010.
17. Bancalari E., Claure N., Sosenko I. R. S. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology, and definition. Semin. Neonatol. 2003; 8: 63–71.
18. Kubota J., Ohki Y., Inoue T., Sakurai M., Shigeta M., Mochizuki H., Aoki J., Morikawa A., Endo K. Ultrafast CT scoring system for assessing bronchopulmonary dysplasia: reproducibility and clinical correlation. Radiat. Med. 1998; 16: 167–174.
19. Давыдова И. В. Формирование, течение и исходы бронхолегочной дисплазии у детей. Автореф. дис. … докт. мед. наук. М. 2010. 48 с.
Review
For citations:
Davydova I.V., Anikin A.V., Kustova O.V., Sidenko A.V., Basargina E.Yu., Pavlyukova E.V., Pozharishchenskaya V.K. Bronchopulmonary Dysplasia in Post-Surfactant Era: Results of an Objective Assessment of the Disease. Current Pediatrics. 2015;14(4):514-518. (In Russ.) https://doi.org/10.15690/vsp.v14.i4.1392
Views:
989
Email this article 
